Quarterly report · Q2

Period2022-04-01 → 2022-09-30
Filed2022-11-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥4.9bn2022-04-01 → 2022-09-30Cons.Net sales
Revenue¥11.8bn2021-04-01 → 2022-03-31Cons.Net sales (5-year summary)
Revenue¥5.5bn2021-04-01 → 2021-09-30Cons.Net sales
Operating income¥210m2022-04-01 → 2022-09-30Cons.Operating income
Operating income¥343m2021-04-01 → 2021-09-30Cons.Operating income
Ordinary income¥203m2022-04-01 → 2022-09-30Cons.Ordinary income
Ordinary income¥889m2021-04-01 → 2022-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥339m2021-04-01 → 2021-09-30Cons.Ordinary income
Profit before tax¥79m2022-04-01 → 2022-09-30Cons.Income before income taxes
Profit before tax¥339m2021-04-01 → 2021-09-30Cons.Income before income taxes
Net income (owners)¥3m2022-04-01 → 2022-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥613m2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥249m2021-04-01 → 2021-09-30Cons.Profit loss attributable to owners of parent
Net income¥3m2022-04-01 → 2022-09-30Cons.Profit loss
Net income¥249m2021-04-01 → 2021-09-30Cons.Profit loss
Total assets¥7.7bnat 2022-09-30Cons.Assets
Total assets¥8.6bnat 2022-03-31Cons.Assets
Total assets¥8.3bnat 2021-09-30Cons.Total assets (5-year summary)
Total liabilities¥5.7bnat 2022-09-30Cons.Liabilities
Total liabilities¥6.6bnat 2022-03-31Cons.Liabilities
Net assets / equity¥2.0bnat 2022-09-30Cons.Net assets
Net assets / equity¥2.0bnat 2022-03-31Cons.Net assets
Net assets / equity¥1.6bnat 2021-09-30Cons.Net assets (5-year summary)
Cash and deposits¥2.0bnat 2022-09-30Cons.Cash and deposits
Cash and deposits¥2.3bnat 2022-03-31Cons.Cash and deposits
Cash & equivalents¥2.0bnat 2022-09-30Cons.Cash and cash equivalents
Cash & equivalents¥2.3bnat 2022-03-31Cons.Cash and cash equivalents
Cash & equivalents¥2.0bnat 2021-09-30Cons.Cash and cash equivalents
Cash & equivalents¥2.1bnat 2021-03-31dCons.Cash and cash equivalents
Operating cash flow¥45m2022-04-01 → 2022-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥1.1bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥291m2021-04-01 → 2021-09-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥31m2022-04-01 → 2022-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥151m2021-04-01 → 2022-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥48m2021-04-01 → 2021-09-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥371m2022-04-01 → 2022-09-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥696m2021-04-01 → 2022-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥326m2021-04-01 → 2021-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥1.142022-04-01 → 2022-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-32.712022-07-01 → 2022-09-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥228.112021-04-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥92.512021-04-01 → 2021-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥40.872021-07-01 → 2021-09-30dCons.Basic earnings loss per share (5-year summary)
Equity ratio26.2%at 2022-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio23.3%at 2022-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio19.7%at 2021-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 37
SegmentItemPeriodValue
jpcrp040300-q2r_E01978-000Dispensing Pharmacy And Related Businessreportable segmentrevenue2022-04-01 → 2022-09-30¥3.3bn
jpcrp040300-q2r_E01978-000Dispensing Pharmacy And Related Businessreportable segmentrevenue external2022-04-01 → 2022-09-30¥3.3bn
jpcrp040300-q2r_E01978-000Dispensing Pharmacy And Related Businessreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥5m
jpcrp040300-q2r_E01978-000Dispensing Pharmacy And Related Businessreportable segmentsegment profit2022-04-01 → 2022-09-30¥116m
jpcrp040300-q2r_E01978-000Internet Related Businessreportable segmentrevenue2022-04-01 → 2022-09-30¥752m
jpcrp040300-q2r_E01978-000Internet Related Businessreportable segmentrevenue external2022-04-01 → 2022-09-30¥746m
jpcrp040300-q2r_E01978-000Internet Related Businessreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥6m
jpcrp040300-q2r_E01978-000Internet Related Businessreportable segmentsegment profit2022-04-01 → 2022-09-30¥70m
jpcrp040300-q2r_E01978-000Telecommunications Businessreportable segmentrevenue2022-04-01 → 2022-09-30¥868m
jpcrp040300-q2r_E01978-000Telecommunications Businessreportable segmentrevenue external2022-04-01 → 2022-09-30¥867m
jpcrp040300-q2r_E01978-000Telecommunications Businessreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥1m
jpcrp040300-q2r_E01978-000Telecommunications Businessreportable segmentsegment profit2022-04-01 → 2022-09-30¥47m
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-09-30¥5.0bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-09-30¥4.9bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-09-30¥12m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-09-30¥233m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2021-04-01 → 2021-09-30−¥103,000
jpcrp040300-q2r_E01978-000Dispensing Pharmacy And Related Businessreportable segmentrevenue2021-04-01 → 2021-09-30¥3.5bn
jpcrp040300-q2r_E01978-000Dispensing Pharmacy And Related Businessreportable segmentrevenue external2021-04-01 → 2021-09-30¥3.5bn
jpcrp040300-q2r_E01978-000Dispensing Pharmacy And Related Businessreportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥5m
jpcrp040300-q2r_E01978-000Dispensing Pharmacy And Related Businessreportable segmentsegment profit2021-04-01 → 2021-09-30¥173m
jpcrp040300-q2r_E01978-000Internet Related Businessreportable segmentrevenue2021-04-01 → 2021-09-30¥591m
jpcrp040300-q2r_E01978-000Internet Related Businessreportable segmentrevenue external2021-04-01 → 2021-09-30¥582m
jpcrp040300-q2r_E01978-000Internet Related Businessreportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥8m
jpcrp040300-q2r_E01978-000Internet Related Businessreportable segmentsegment profit2021-04-01 → 2021-09-30¥51m
jpcrp040300-q2r_E01978-000Telecommunications Businessreportable segmentrevenue2021-04-01 → 2021-09-30¥1.5bn
jpcrp040300-q2r_E01978-000Telecommunications Businessreportable segmentrevenue external2021-04-01 → 2021-09-30¥1.5bn
jpcrp040300-q2r_E01978-000Telecommunications Businessreportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥12m
jpcrp040300-q2r_E01978-000Telecommunications Businessreportable segmentsegment profit2021-04-01 → 2021-09-30¥170m
—segment totalrevenue2021-04-01 → 2021-09-30¥5.5bn
—segment totalrevenue external2021-04-01 → 2021-09-30¥5.5bn
—segment totalrevenue intersegment2021-04-01 → 2021-09-30¥26m
—segment totalsegment profit2021-04-01 → 2021-09-30¥395m
Total Of Reportable Segments And Otherssegment totalrevenue2021-04-01 → 2021-09-30¥5.5bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-04-01 → 2021-09-30¥5.5bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2021-04-01 → 2021-09-30¥26m
Total Of Reportable Segments And Otherssegment totalsegment profit2021-04-01 → 2021-09-30¥395m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 530
ItemContextValueUnit
Description issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember-
Treasury shares etc (text)FilingDateInstantText · Plus
Name of shareholder treasury shares etcCurrentQuarterInstant_Row1Member
Original text (Japanese)株式会社ソフィアホールディングス
Address of shareholder treasury shares etcCurrentQuarterInstant_Row1Member
Original text (Japanese)神奈川県横浜市港北区新横浜二丁目15番12号
Information about officers (text)FilingDateInstantText · Plus
Regulations in accordance with which consolidated financial statements have been prepared financial informationCurrentYTDDurationText · Plus
Note on independent audit financial informationCurrentYTDDurationText · Plus
Quarterly consolidated balance sheet (text)CurrentYTDDurationText · Plus
Year to quarter end consolidated statement of income (text)CurrentYTDDurationText · Plus
Year to quarter end consolidated statement of comprehensive income (text)CurrentYTDDurationText · Plus
Quarterly consolidated statement of cash flows (text)CurrentYTDDurationText · Plus
Notes additional information quarterly consolidated financial statements (text)CurrentYTDDurationText · Plus
Notes regarding presentation of accumulated impairment loss (text)CurrentQuarterInstantText · Plus
Debtors notes regarding overdraft contracts and or loan commitments (text)CurrentQuarterInstantText · Plus
Notes regarding financial covenant (text)CurrentQuarterInstantText · Plus
Major components of selling general and administrative expenses (text)CurrentYTDDurationText · Plus
Special survey costs etc (text)CurrentYTDDurationText · Plus
Reconciliation of ending balance of cash and cash equivalents with account balances per balance sheet (text)CurrentYTDDurationText · Plus
Notes segment information etc quarterly consolidated financial statements (text)CurrentYTDDurationText · Plus
Footnotes regarding segment information table (text)Prior1YTDDurationText · Plus
Description of nature of differences between profit loss of reportable segments total and quarterly financial statements (text)Prior1YTDDurationText · Plus
Information about impairment loss of non current assets or goodwill etc for each reportable segment (text)Prior1YTDDurationText · Plus
Disclosure of changes etc in reportable segments (text)CurrentYTDDurationText · Plus
Description of nature of differences between profit loss of reportable segments total and quarterly financial statements (text)CurrentYTDDurationText · Plus
Information about impairment loss of non current assets or goodwill etc for each reportable segment (text)CurrentYTDDurationText · Plus
Notes revenue recognition quarterly consolidated financial statements (text)CurrentYTDDurationText · Plus
Notes per share information quarterly consolidated financial statements (text)CurrentYTDDurationText · Plus
Notes significant events after reporting period quarterly consolidated financial statements (text)CurrentYTDDurationText · Plus
Other information consolidated financial statements etc (text)CurrentYTDDurationText · Plus
Information about company which provides guarantee to reporting company (text)FilingDateInstantText · Plus

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2022-03-31pass
balance sheet identityconsolidated 2022-09-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsconsolidated 2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2021-04-01/2021-09-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-09-30pass
statement vs summary · revenueconsolidated 2021-04-01/2021-09-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-09-30pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-09-30pass